Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis-Reference-Cited by-同舟云学术

Leukemia inhibitory factor is a therapeutic target for renal interstitial fibrosis

Published:2022-12 Issue: Volume:86 Page:104312
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Xu Shihui,Yang Xiaobing,Chen Qingzhou,Liu Zhuoliang,Chen Ying,Yao Xiaotian,Xiao An,Tian Jianwei,Xie Liling,Zhou Miaomiao,Hu Zheng,Zhu Fengxin,Xu Xin,Hou Fanfan,Nie Jing^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference96 articles.

1. Chronic kidney disease diagnosis and management: a review;Chen;JAMA,2019

2. Detailed review of chronic kidney disease;Kakitapalli;Kidney Dis (Basel),2020

3. Cellular and molecular mechanisms of renal fibrosis;Liu;Nat Rev Nephrol,2011

4. Cellular and molecular mechanisms of kidney fibrosis;Djudjaj;Mol Aspects Med,2019

5. Origin and function of myofibroblasts in kidney fibrosis;Lebleu;Nat Med,2013

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The novel peptide PEP-Z-2 potentially treats renal fibrosis in vivo and in vitro by regulating TGF-β/Smad/AKT/MAPK signaling;European Journal of Pharmacology;2024-11

2. Spatial transcriptomics defines injury specific microenvironments and cellular interactions in kidney regeneration and disease;Nature Communications;2024-09-05

3. Renal tubular epithelial cell quality control mechanisms as therapeutic targets in renal fibrosis;Journal of Pharmaceutical Analysis;2024-08

4. Identification of novel immune-related signatures for keloid diagnosis and treatment: insights from integrated bulk RNA-seq and scRNA-seq analysis;Human Genomics;2024-07-16

5. Role of circulating inflammatory protein in the development of diabetic renal complications: proteome-wide Mendelian randomization and colocalization analyses;Frontiers in Endocrinology;2024-07-08